Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical Infectious Diseases

• Publication date

  2006-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1086/500939PMID 16511756
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard

  2008cited by this paper
• Liposomal amphotericin B: clinical experience and perspectives

  2005cited by this paper
• Caspofungin Susceptibility Testing of Isolates from Patients with Esophageal Candidiasis or Invasive Candidiasis: Relationship of MIC to Treatment Outcome

  2005cited by this paper
• Seminational Surveillance of Fungemia in Denmark: Notably High Rates of Fungemia and Numbers of Isolates with Reduced Azole Susceptibility

  2005cited by this paper
• Caspofungin Resistance in Candida albicans: Correlating Clinical Outcome with Laboratory Susceptibility Testing of Three Isogenic Isolates Serially Obtained from a Patient with Progressive Candida Esophagitis

  2004cited by this paper
• Geographic Variation in the Susceptibilities of Invasive Isolates of Candida glabrata to Seven Systemically Active Antifungal Agents: a Global Assessment from the ARTEMIS Antifungal Surveillance Program Conducted in 2001 and 2002

  2004cited by this paper
• Clinical utility of antifungal pharmacokinetics and pharmacodynamics

  2004cited by this paper
• Patterns of Amphotericin B Killing Kinetics against Seven Candida Species

  2004cited by this paper
• Evaluation of the Etest Method Using Mueller-Hinton Agar with Glucose and Methylene Blue for Determining Amphotericin B MICs for 4,936 Clinical Isolates of Candida Species

  2004cited by this paper
• Genetic Diversity among Clinical Isolates of Candida glabrata Analyzed by Randomly Amplified Polymorphic DNA and Multilocus Enzyme Electrophoresis Analyses

  2003cited by this paper
• Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts

  2003cited by this paper
• Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors.

  2003cited by this paper
• In Vivo Pathogenicity of Eight Medically Relevant Candida Species in an Animal Model

  2002influential reference
• Trends in Antifungal Susceptibility of Candida spp. Isolated from Pediatric and Adult Patients with Bloodstream Infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000

  2002cited by this paper
• Amphotericin B: spectrum and resistance.

  2002cited by this paper
• Antibiotic resistance surveillance: action for international studies.

  2002cited by this paper
• Molecular genotyping of Candida species with special respect to Candida (Torulopsis) glabrata strains by arbitrarily primed PCR.

  2000cited by this paper
• Assessment of the Effect of Amphotericin B on the Vitality of Candida albicans

  1999cited by this paper
• Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B.

  1998cited by this paper
• Development and verification of fingerprinting probes for Candida glabrata.

  1997cited by this paper
• Detection of amphotericin B-resistant Candida isolates in a broth-based system

  1995cited by this paper
• Taq polymerase contains bacterial DNA of unknown origin.

  1990cited by this paper

• [1,3]Thiazolo[3,2-b][1,2,4]triazolium Salts as Effective Antimicrobial Agents: Synthesis, Biological Activity Evaluation, and Molecular Docking Studies

  2025cites this paper
• Otilonium bromide exhibits novel antifungal activity against Candida albicans via regulating iron homeostasis

  2025cites this paper
• Identification of Candida species from blood samples of neonates by PCR-RFLP method in Western U.P

  2024cites this paper
• Nosocomial transmission of fluconazole-resistant Candida glabrata bloodstream isolates revealed by whole-genome sequencing

  2024cites this paper
• Treatment of vaginitis caused by non-albicans Candida species

  2024cites this paper
• Whole-Genome Sequence Analysis of Candida glabrata Isolates from a Patient with Persistent Fungemia and Determination of the Molecular Mechanisms of Multidrug Resistance

  2023cites this paper
• Antifungal susceptibility profile and biofilm production of Candida spp. isolated from catheterised patients with urinary tract infection

  2022cites this paper
• Investigation of the Defective Growth Pattern and Multidrug Resistance in a Clinical Isolate of Candida glabrata Using Whole-Genome Sequencing and Computational Biology Applications

  2022cites this paper
• Potential inhibitory activity of phytoconstituents against black fungus: In silico ADMET, molecular docking and MD simulation studies

  2022cites this paper
• Resistance to Antifungal Drugs.

  2021cites this paper
• Antifungal Susceptibility Testing and Identification.

  2021cites this paper
• A Review on Molecular Mechanisms of Antifungal Resistance in Candida glabrata: Update and Recent Advances

  2021cites this paper
• In vitro pharmacokinetic/pharmacodynamic model data suggest a potential role of new formulations of posaconazole against C. krusei but not C. glabrata infections.

  2021cites this paper
• Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?

  2021cites this paper
• Immunotherapy and Antifungal Drugs of Candidiasis: Achievements and Challenges

  2021cites this paper
• Antifungal susceptibility profile of invasive Candida glabrata isolates (2009-2020) from a tertiary care hospital laboratory in Pakistan.

  2021cites this paper
• Antifungal Susceptibility Testing: A Primer for Clinicians

  2021cites this paper
• Emerging Prospects for Combating Fungal Infections by Targeting Phosphatidylinositol Transfer Proteins

  2021cites this paper
• p-Coumaric acid loaded into liquid crystalline systems as a novel strategy to the treatment of vulvovaginal candidiasis.

  2021cites this paper
• Should Etest MICs for Yeasts Be Categorized by Reference (BPs/ECVs) or by Etest (ECVs) Cutoffs as Determinants of Emerging Resistance?

  2020cites this paper
• Review of the Current Management of Urinary Tract Infections due to Fluconazole-Resistant and Non-Albicans Candida Species

  2020cites this paper
• Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection

  2019cites this paper
• Antifungal Resistance Testing and Implications for Management

  2019cites this paper
• In-vitro Control of Oral Thrush Causal Organisms Using Medicinal Plants Extracts

  2019cites this paper
• Genome-Wide Response to Drugs and Stress in the Pathogenic Yeast Candida glabrata.

  2019cites this paper
• Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases.

  2019cites this paper
• ERG6 and ERG2 Are Major Targets Conferring Reduced Susceptibility to Amphotericin B in Clinical Candida glabrata Isolates in Kuwait

  2018cites this paper
• The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.

  2018cites this paper
• Interactions between Candida albicans and Candida glabrata in biofilms: Influence of the strain type, culture medium and glucose supplementation

  2018cites this paper
• Candiduria; a review article with specific data from Iran.

  2018cites this paper
• Ассоциированная с мутациями генов FKS резистентность Candida glabrata к эхинокандинам: насколько актуальна проблема?

  2018cites this paper
• In Vitro Susceptibilities of Non-albicans Candida Species to Echinocandins, Azoles, and Amphotericin B in Tokat, Turkey

  2018cites this paper
• Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens

  2018cites this paper
• In vitro antifungal susceptibilities of Candida species to liposomal amphotericin B, determined using CLSI broth microdilution, and amphotericin B deoxycholate, measured using the Etest

  2017cites this paper
• Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp.

  2017cites this paper
• Selected Essential Oils as Antifungal Agents Against Antibiotic-Resistant Candida spp.: In Vitro Study on Clinical and Food-Borne Isolates

  2017cites this paper
• Future therapies targeted towards eliminating Candida biofilms and associated infections

  2017cites this paper
• Candida glabrata Biofilms: How Far Have We Come?

  2017cites this paper
• Oral mucositis caused by Candida glabrata biofilms: failure of the concomitant use of fluconazole and ascorbic acid

  2017cites this paper
• Applications of Spider Venom in Medical Science and Agriculture

  2016cites this paper
• Candidemia in patients with prolonged fever in Kashan, Iran

  2016cites this paper
• Suspected encephalitis with Candida tropicalis and Fusarium detected by unbiased RNA sequencing

  2016cites this paper
• Caspofungin MIC Distribution amongst Commonly Isolated Candida Species in a Tertiary Care Centre - An Indian Experience.

  2016cites this paper
• Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - Trends over 10 years.

  2016cites this paper
• Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus

  2016cites this paper
• Antifungal drug resistance in pathogenic fungi

  2016cites this paper
• In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen

  2016cites this paper
• Management of Candida biofilms: state of knowledge and new options for prevention and eradication.

  2016cites this paper
• Candida glabrata's recurrent infections: biofilm formation during Amphotericin B treatment

  2016cites this paper
• Difficulties in antifungal therapy with amphotericin B and the continuous search for new formulations: A literature review

  2016influential citation
• Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults

  2016cites this paper
• Synthesis and Antifungal Screening of 2-{[1-(5-Alkyl/arylalkylpyrazin-2-yl)ethylidene]hydrazono}-1,3-thiazolidin-4-ones †

  2016cites this paper
• A Review of Antifungal Peptides: Basis to New Era of Antifungal Drugs

  2016cites this paper
• The Susceptibility Patterns of Candida Species Isolated From Urine Samples to Posaconazole and Caspofungin

  2015cites this paper
• In vitro activity of 23 tea extractions and epigallocatechin gallate against Candida species.

  2015cites this paper
• Tipping the balance both ways: drug resistance and virulence in Candida glabrata.

  2015cites this paper
• Candida glabrata: new tools and technologies—expanding the toolkit

  2015cites this paper
• Multidrug- and Cross-Resistant Candida: the Looming Threat

  2015cites this paper
• Hb40-61a: Novel analogues help expanding the knowledge on chemistry, properties and candidacidal action of this bovine α-hemoglobin-derived peptide.

  2015cites this paper
• CHANGING TRENDS OF CANDIDA ISOLATES AND THEIR ANTIFUNGAL SUSCEPTIBILITY PATTERN IN VULVOVAGINAL CANDIDIASIS CASES OF TRIPURA, NORTH EAST INDIA

  2015cites this paper
• Effect of fetal bovine serum on Candida glabrata cultures

  2015cites this paper
• Antifungal drug resistance among Candida species: mechanisms and clinical impact

  2015cites this paper
• Antimicrobial activity of four medicinal plants widely used in Persian folk medicine

  2015cites this paper
• Role of FKS Mutations in Candida glabrata: MIC Values, Echinocandin Resistance, and Multidrug Resistance

  2014cites this paper
• Epidemiology of Invasive Candidiasis and Challenges for the Mycology Laboratory: Specificities of Candida glabrata

  2014cites this paper
• Is Timely and Appropriate Antifungal Drug Enough for Survival of Adult Cases with Candidaemia? Five-year Experience.

  2014cites this paper
• La resistencia a antibióticos: El efecto colateral

  2014cites this paper
• Pharmacokinetics and Pharmacodynamics of Antifungals in Children and their Clinical Implications

  2014cites this paper
• Bifonazole in vitro activity and its azole-parallel resistance in clinical yeast isolates

  2014cites this paper
• Current status of antifungal resistance and its impact on clinical practice

  2014cites this paper
• Candida bloodstream infection: a clinical microbiology laboratory perspective.

  2014cites this paper
• Antifungal susceptibility of Candida isolates at one institution.

  2014cites this paper
• Candida glabrata vertebral osteomyelitis in an immunosuppressed patient

  2014cites this paper
• Systematic Phenotyping of a Large-Scale Candida glabrata Deletion Collection Reveals Novel Antifungal Tolerance Genes

  2014cites this paper
• Isolation of cholesterol-dependent, multidrug-resistant Candida glabrata strains from blood cultures of a candidemia patient in Kuwait

  2014cites this paper
• Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?

  2014cites this paper
• SPECIATION AND ANTIFUNGAL SUSCEPTIBILITY PATTERN OF CANDIDA ISOLATES IN A TERTIARY CARE HOSPITAL

  2014cites this paper
• Candida glabrata and FKS mutations: witnessing the emergence of the true multidrug-resistant Candida.

  2013cites this paper
• Candida and candidaemia. Susceptibility and epidemiology.

  2013cites this paper
• SYNTHESIS OF SOME NOVEL THIAZOLES, BISTHIAZOLES, THIAZOLIN-4 ONES AND 1,3,4 THIADIAZOLINE COMPOUNDS STARTING FROM 5-ACETYL-2-PHENYL-4-METHYL- THIAZOLYL-THIOSEMICARBAZONE

  2013cites this paper
• Synthesis and antimicrobial activity of some new hydrazone-bridged thiazole-pyrrole derivatives

  2013cites this paper
• Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents

  2013cites this paper
• Functional characterisation of Candida glabrata open reading frames with no orthologue in Saccharomyces cerevisiae

  2013cites this paper
• Structural and biochemical characterisation of enzymes involved in mannan biosynthesis

  2013cites this paper
• Caracterização e Identificação de Fungos Causadores de Infecções Nosocomiais em Pacientes Transplantados de Células Tronco Hematopoiéticas

  2013cites this paper
• Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.

  2013cites this paper
• Design, Development, and Characterization of Novel Antimicrobial Peptides for Pharmaceutical Applications

  2013cites this paper
• Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata

  2012cites this paper
• A review of Candida species causing blood stream infection.

  2012cites this paper
• "PEPTÍDEOS ANTIMICROBIANOS DO VENENO DE Avicularia juruensis (Mygalomorphae, Theraphosidae)"

  2012cites this paper
• Echinocandin Antifungal Drugs in Fungal Infections

  2012cites this paper
• Caspofungin for the Treatment of Immunocompromised and Severely Ill Children and Neonates with Invasive Fungal Infections

  2012cites this paper
• Interactions of Yeasts, Moulds, and Antifungal Agents

  2012cites this paper
• Use of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry for Caspofungin Susceptibility Testing of Candida and Aspergillus Species

  2012cites this paper
• Caspofungin: when and how? The microbiologist’s view

  2012cites this paper
• Differential In Vivo Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without FKS Resistance Mutations

  2012cites this paper
• Candida glabrata: Multidrug Resistance and Increased Virulence in a Major Opportunistic Fungal Pathogen

  2012cites this paper
• Facultative Sterol Uptake in an Ergosterol-Deficient Clinical Isolate of Candida glabrata Harboring a Missense Mutation in ERG11 and Exhibiting Cross-Resistance to Azoles and Amphotericin B

  2012cites this paper
• Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008.

  2012cites this paper
• Antifungal therapy for newborn infants with invasive fungal infection.

  2012cites this paper